deltatrials
Completed NCT00004351

Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes

Sponsor: Baylor College of Medicine

Conditions Angelman Syndrome Chromosome Abnormalities DiGeorge Syndrome Prader-Willi Syndrome Shprintzen Syndrome Smith-Magenis Syndrome Williams Syndrome
Updated 6 times since 2017 Last updated: Jun 23, 2005 Started: Sep 30, 1999

A observational or N/A phase clinical study on Angelman Syndrome and Chromosome Abnormalities, this trial is completed. The trial is conducted by Baylor College of Medicine and has accumulated 6 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Sep 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baylor College of Medicine
  • National Institute of Neurological Disorders and Stroke (NINDS)
Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Houston, United States